Item
The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from infectious diseas…
Read and enrich the people, organizations and context referenced in case files.
Explore the cases that include this wiki entry.
No case files include this entry yet.
Investigate this subjectThe Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from infectious diseases. GloPID-R is intended to be a means for facilitating communication and collaboration between its member bodies, as opposed to a funding or disaster response entity.
The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) is an international initiative to anticipate and prepare for future threats from infectious diseases. GloPID-R is intended to be a means for facilitating communication and collaboration between its member bodies, as opposed to a funding or disaster response entity. Its secretariat is funded by the European Union through its Horizon 2020 initiative.
GloPID-R was launched in February 2013 in Brussels, Belgium on the recommendation of the Heads of International Research Organizations (HIROs).
On February 11–12, 2020, GloPID-R co-hosted an event with the World Health Organization's R&D Blueprint called “2019 novel Coronavirus Global research and innovation forum: towards a research roadmap”. Participants in this conference identified a number of key research priorities which served as the basis on which funding decisions were made in response to the COVID-19 pandemic.
GloPID-R's membership is made up of national research funding agencies, academic research institutes and philanthropic organizations. The World Health Organization (WHO), Coalition for Epidemic Preparedness Innovations (CEPI) and European and Developing Countries Clinical Trials Partnership (EDCCTP) serve as observers.
As of February 2023, GloPID-R's member organizations were as follows:
Source: Global Research Collaboration for Infectious Disease Preparedness (CC BY-SA)
We label verified structured information, user opinions, and AI-discovered relationships separately.
Be the first to comment.
